These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35141760)

  • 1. Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729.
    Huang R; Li B; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):471-485. PubMed ID: 35141760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate.
    Yu Q; Gratzke C; Wang R; Li B; Kuppermann P; Herlemann A; Tamalunas A; Wang Y; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
    J Biol Chem; 2019 Aug; 294(32):12231-12249. PubMed ID: 31243101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picotamide inhibits a wide spectrum of agonist-induced smooth muscle contractions in porcine renal interlobar and coronary arteries.
    Li B; Huang R; Wang R; Liu Y; Stief CG; Hennenberg M
    Pharmacol Res Perspect; 2021 May; 9(3):e00771. PubMed ID: 33929093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADP Ribosylation Factor 6 Promotes Contraction and Proliferation, Suppresses Apoptosis and Is Specifically Inhibited by NAV2729 in Prostate Stromal Cells.
    Wang R; Schneider S; Keppler OT; Li B; Rutz B; Ciotkowska A; Stief CG; Hennenberg M
    Mol Pharmacol; 2021 Oct; 100(4):356-371. PubMed ID: 34349027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gα
    Tamalunas A; Wendt A; Springer F; Ciotkowska A; Rutz B; Wang R; Huang R; Liu Y; Schulz H; Ledderose S; Magistro G; Stief CG; Hennenberg M
    Front Physiol; 2022; 13():884057. PubMed ID: 35677088
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region.
    Hennenberg M; Tamalunas A; Wang Y; Keller P; Schott M; Strittmatter F; Herlemann A; Yu Q; Rutz B; Ciotkowska A; Stief CG; Gratzke C
    Eur J Pharmacol; 2017 May; 803():39-47. PubMed ID: 28315343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of neurogenic and thromboxane A
    Li B; Wang X; Wang R; Rutz B; Ciotkowska A; Gratzke C; Herlemann A; Spek A; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Prostate; 2020 Aug; 80(11):831-849. PubMed ID: 32449814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle.
    Hu S; Trieb M; Huang R; Tamalunas A; Keller P; Götz M; Waidelich R; Stief CG; Hennenberg M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1219-1231. PubMed ID: 37658212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Full Smooth Muscle Contraction in Isolated Human Detrusor Tissues by Mirabegron Is Limited to Off-Target Inhibition of Neurogenic Contractions.
    Huang R; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    J Pharmacol Exp Ther; 2022 May; 381(2):176-187. PubMed ID: 35153197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbance of the prejunctional modulation of cholinergic neurotransmission during chronic granulomatous inflammation of the mouse ileum.
    De Man JG; Moreels TG; De Winter BY; Bogers JJ; Van Marck EA; Herman AG; Pelckmans PA
    Br J Pharmacol; 2001 Jul; 133(5):695-707. PubMed ID: 11429394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusor.
    Li B; Wang X; Rutz B; Wang R; Tamalunas A; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):829-842. PubMed ID: 31867686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of smooth muscle contraction and ARF6 activity by the inhibitor for cytohesin GEFs, secinH3, in the human prostate.
    Herlemann A; Keller P; Schott M; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Yu Q; Waidelich R; Strittmatter F; Stief CG; Gratzke C; Hennenberg M
    Am J Physiol Renal Physiol; 2018 Jan; 314(1):F47-F57. PubMed ID: 28855187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of neurogenic, but not agonist-induced contractions by phospholipase A
    Hu S; Huang R; Keller P; Götz M; Tamalunas A; Weinhold P; Waidelich R; Stief CG; Hennenberg M
    Neurourol Urodyn; 2023 Sep; 42(7):1522-1531. PubMed ID: 37583250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic intervention.
    Yu Q; Gratzke C; Wang Y; Wang X; Li B; Strittmatter F; Herlemann A; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Prostate; 2019 May; 79(7):746-756. PubMed ID: 30811062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle.
    Hennenberg M; Miljak M; Herrmann D; Strittmatter F; Walther S; Rutz B; Hocaoglu Y; Kunit T; Schreiber A; Andersson KE; Stief CG; Gratzke C
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1383-90. PubMed ID: 24049147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983.
    Huang R; Liu Y; Li B; Wang R; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Prostate; 2022 Jan; 82(1):59-77. PubMed ID: 34633103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependent alpha
    Huang R; Liu Y; Ciotkowska A; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Front Pharmacol; 2021; 12():666047. PubMed ID: 34248624
    [No Abstract]   [Full Text] [Related]  

  • 18. Does coupling to ADP ribosylation factor 6 explain differences between muscarinic and other receptors in interaction with β-adrenoceptor-mediated smooth muscle relaxation?
    Erdogan BR; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):381-386. PubMed ID: 35175382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005.
    Hennenberg M; Schott M; Kan A; Keller P; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Strittmatter F; Herlemann A; Yu Q; Stief CG; Gratzke C
    Prostate; 2016 Nov; 76(15):1364-74. PubMed ID: 27418235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α
    Wang X; Li B; Ciotkowska A; Rutz B; Erlander MG; Ridinger M; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Eur J Pharmacol; 2020 Apr; 873():172985. PubMed ID: 32017934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.